In patients with chronic Helicobacter pylori (H pylori) infection, parietal and chief cell atrophy in the gastric corpus, a process known as spasmolytic polypeptide-expressing metaplasia (SPEM), increases the risk for progression to cancer. The relationship between H pylori and these metaplastic changes is unclear. We investigated whether H pylori localizes to regions of SPEM.